Drug Approval | August 31, 2023
Ajanta Pharma receives USFDA for Topiramate Extended Release Capsules
Topiramate is the generic version of Supernus Pharmaceuticals’ Trokendi XR
Topiramate is the generic version of Supernus Pharmaceuticals’ Trokendi XR
India will account for about 18% of the Asia-Pacific (APAC) MRI systems market in 2023
Guaifenesin extended-release tablets help to loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
Global Initiative on Digital Health launched at the G2O Health Minister’s Meeting
The campaign seeks to raise awareness about hypertension while emphasising the significance of managing blood pressure for a healthier lifestyle
Need to harmonize traditional and modern medicine to combat alarming health problems
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
Deep Transcranial Magnetic Stimulation (dTMS) is a non-invasive brain stimulation technique approved by regulatory authorities, including the USFDA
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
Senvelgo is the first liquid once-daily, orally administered prescription medication to improve glycemic control in cats with diabetes mellitus
Subscribe To Our Newsletter & Stay Updated
